Why Peptides Matter and What the FDA Doesn’t Want to Approve
Whether you are just hearing about peptides or already deep in the rabbit hole, this episode will open your eyes to what is possible.
In this episode of DeSci Pilled, host Ryan Bethencourt speaks with Hannah Schick and Gregory Gopman, the co-founders of PeptideDAO.
Together they explore how peptides are unlocking a new era in health, wellness, and longevity, and why decentralized science (DeSci) is the key to making it accessible.
Peptides may be one of the most promising frontiers in healthcare, with the potential to impact everything from muscle growth and fat loss to skincare and disease prevention. But most peptides cannot be patented, meaning pharmaceutical companies have little incentive to fund research or pursue FDA approval.
PeptideDAO aims to change that. By using a community-driven model, they are bringing rigorous science, transparency, and real-world impact to an otherwise fragmented and unregulated space.
Watch the episode.